Active, not recruitingNot applicableNCT06781294

SIRAKI 02 Posthoc Analysis.

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Universitari de Bellvitge
Intervention
Extracorporeal Cytokine hemadsorption therapy(device)
Enrollment
343 target
Eligibility
18 years · All sexes
Timeline
2024 – 2027

Study locations (1)

Collaborators

University of Barcelona · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Germans Trias i Pujol Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06781294 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease →

← Back to all trials